$CWBHF

2024 Q3 Form 10-Q Financial Statement

#000175015524000059 Filed on August 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $12.59M $12.29M
YoY Change -11.94% -23.22%
Cost Of Revenue $5.914M $9.707M
YoY Change -7.09% 36.95%
Gross Profit $6.673M $2.582M
YoY Change -15.84% -71.05%
Gross Profit Margin 53.02% 21.01%
Selling, General & Admin $12.69M $14.73M
YoY Change -36.18% -24.97%
% of Gross Profit 190.21% 570.37%
Research & Development $648.0K
YoY Change -29.26%
% of Gross Profit 25.1%
Depreciation & Amortization $2.489M
YoY Change -37.42%
% of Gross Profit 96.4%
Operating Expenses $12.69M $14.73M
YoY Change -36.18% -24.97%
Operating Profit -$6.020M -$12.15M
YoY Change -49.67% 13.41%
Interest Expense $1.140M
YoY Change -92.36%
% of Operating Profit
Other Income/Expense, Net -$1.189M -$6.000K
YoY Change -241.38% -99.56%
Pretax Income -$5.787M -$11.01M
YoY Change -61.78% -487.17%
Income Tax $0.00 $46.00K
% Of Pretax Income
Net Earnings -$5.787M -$11.06M
YoY Change -61.78% -488.78%
Net Earnings / Revenue -45.98% -89.97%
Basic Earnings Per Share -$0.04 -$0.07
Diluted Earnings Per Share -$0.04 -$0.07
COMMON SHARES
Basic Shares Outstanding 157.5M shares 157.2M shares
Diluted Shares Outstanding 157.5M shares 157.2M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $32.53M
YoY Change -47.3%
Cash & Equivalents $24.62M $32.53M
Short-Term Investments
Other Short-Term Assets $3.857M
YoY Change -44.1%
Inventory $19.53M $18.67M
Prepaid Expenses
Receivables $1.605M $1.869M
Other Receivables $0.00
Total Short-Term Assets $49.99M $56.93M
YoY Change -40.3% -39.99%
LONG-TERM ASSETS
Property, Plant & Equipment $27.10M $28.20M
YoY Change -3.4% 5.98%
Goodwill
YoY Change
Intangibles $1.082M $1.166M
YoY Change -21.71% -22.27%
Long-Term Investments $11.40M $11.20M
YoY Change 2.7% 4.67%
Other Assets $648.0K $534.0K
YoY Change -53.35% -64.75%
Total Long-Term Assets $69.65M $72.86M
YoY Change -13.07% -10.84%
TOTAL ASSETS
Total Short-Term Assets $49.99M $56.93M
Total Long-Term Assets $69.65M $72.86M
Total Assets $119.6M $129.8M
YoY Change -26.99% -26.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.357M $4.350M
YoY Change -6.15% 36.24%
Accrued Expenses $5.601M $6.669M
YoY Change -22.43% -20.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $16.48M $18.47M
YoY Change -33.49% -18.32%
LONG-TERM LIABILITIES
Long-Term Debt $43.46M
YoY Change 7.81%
Other Long-Term Liabilities $32.04M
YoY Change -9.25%
Total Long-Term Liabilities $75.50M
YoY Change -0.16%
TOTAL LIABILITIES
Total Short-Term Liabilities $16.48M $18.47M
Total Long-Term Liabilities $75.50M
Total Liabilities $89.40M $93.97M
YoY Change -10.71% -4.34%
SHAREHOLDERS EQUITY
Retained Earnings -$298.2M -$292.4M
YoY Change 13.32% 17.91%
Common Stock $1.000K $1.000K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $30.24M $35.83M
YoY Change
Total Liabilities & Shareholders Equity $119.6M $129.8M
YoY Change -26.99% -26.5%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$5.787M -$11.06M
YoY Change -61.78% -488.78%
Depreciation, Depletion And Amortization $2.489M
YoY Change -37.42%
Cash From Operating Activities -$4.704M
YoY Change -542.11%
INVESTING ACTIVITIES
Capital Expenditures $1.256M
YoY Change 571.66%
Acquisitions
YoY Change
Other Investing Activities $1.000K
YoY Change -98.68%
Cash From Investing Activities -$1.255M
YoY Change 1030.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -20.00K
YoY Change 233.33%
NET CHANGE
Cash From Operating Activities -4.704M
Cash From Investing Activities -1.255M
Cash From Financing Activities -20.00K
Net Change In Cash -5.979M
YoY Change -731.36%
FREE CASH FLOW
Cash From Operating Activities -$4.704M
Capital Expenditures $1.256M
Free Cash Flow -$5.960M
YoY Change -779.59%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
375000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
61728000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
77505000 usd
us-gaap Net Income Loss
NetIncomeLoss
-20691000 usd
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
157495042 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
157495042 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
154332366 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
154332366 shares
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2912000 usd
us-gaap Net Income Loss
NetIncomeLoss
-67000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4982000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7769000 usd
us-gaap Inventory Write Down
InventoryWriteDown
3926000 usd
us-gaap Inventory Write Down
InventoryWriteDown
320000 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
1931000 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
1954000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1079000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
999000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
908000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
976000 usd
cweb Change In Fair Value Of Financial Instruments Gain Loss
ChangeInFairValueOfFinancialInstrumentsGainLoss
-720000 usd
cweb Change In Fair Value Of Financial Instruments Gain Loss
ChangeInFairValueOfFinancialInstrumentsGainLoss
9612000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
0 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
10700000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
1430000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-979000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
238000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
957000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
154000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1104000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1025000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2878000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1732000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-764000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-286000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
183000 usd
cweb Increase Decrease In Operating Lease Right Of Use Assets And Operating Lease Liability
IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndOperatingLeaseLiability
1121000 usd
cweb Increase Decrease In Operating Lease Right Of Use Assets And Operating Lease Liability
IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndOperatingLeaseLiability
1436000 usd
cweb Increase Decrease In License Payable
IncreaseDecreaseInLicensePayable
2500000 usd
cweb Increase Decrease In License Payable
IncreaseDecreaseInLicensePayable
4000000 usd
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
0 usd
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-4261000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
192000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
130000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11883000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5009000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
3316000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
187000 usd
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
28000 usd
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
36000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3288000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-151000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-118000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-75000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-118000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-75000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-15289000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5235000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47820000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
66963000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32531000 usd
cweb Noncash Or Part Noncash Acquisition Property And Equipment And Intangible Assets Acquired
NoncashOrPartNoncashAcquisitionPropertyAndEquipmentAndIntangibleAssetsAcquired
269000 usd
cweb Noncash Or Part Noncash Acquisition Property And Equipment And Intangible Assets Acquired
NoncashOrPartNoncashAcquisitionPropertyAndEquipmentAndIntangibleAssetsAcquired
163000 usd
us-gaap Notes Issued1
NotesIssued1
0 usd
us-gaap Notes Issued1
NotesIssued1
156000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12289000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16006000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
24413000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
33016000 usd
CY2024Q2 cweb Business Combination Purchase Option
BusinessCombinationPurchaseOption
745000 usd
CY2024Q2 us-gaap Derivative Assets
DerivativeAssets
691000 usd
CY2024Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
1436000 usd
CY2024Q2 us-gaap Equity Method Investments
EquityMethodInvestments
11200000 usd
CY2024Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
2892000 usd
CY2023Q4 cweb Business Combination Purchase Option
BusinessCombinationPurchaseOption
1730000 usd
CY2023Q4 us-gaap Derivative Assets
DerivativeAssets
872000 usd
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
2602000 usd
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
11000000 usd
CY2023Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
3213000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
10700000 usd
CY2023Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
10700000 usd
CY2021 cweb Payment For Business Combination Purchase Option
PaymentForBusinessCombinationPurchaseOption
8000000 usd
CY2021 cweb Business Combination Purchase Option Term
BusinessCombinationPurchaseOptionTerm
P5Y
CY2021 cweb Business Combination Purchase Option Extension Term
BusinessCombinationPurchaseOptionExtensionTerm
P2Y
CY2021 cweb Class Of Warrant Or Right Percentage Of Outstanding Shares
ClassOfWarrantOrRightPercentageOfOutstandingShares
0.10
CY2021Q4 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P60D
CY2024Q2 cweb Gain Loss On Fair Value Adjustment Business Combination Purchase Option
GainLossOnFairValueAdjustmentBusinessCombinationPurchaseOption
-34000 usd
CY2023Q2 cweb Gain Loss On Fair Value Adjustment Business Combination Purchase Option
GainLossOnFairValueAdjustmentBusinessCombinationPurchaseOption
57000 usd
cweb Gain Loss On Fair Value Adjustment Business Combination Purchase Option
GainLossOnFairValueAdjustmentBusinessCombinationPurchaseOption
-985000 usd
cweb Gain Loss On Fair Value Adjustment Business Combination Purchase Option
GainLossOnFairValueAdjustmentBusinessCombinationPurchaseOption
-243000 usd
CY2024Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
8009000 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
9300000 usd
CY2024Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
12153000 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
9726000 usd
CY2024Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
5751000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
6320000 usd
CY2024Q2 us-gaap Inventory Gross
InventoryGross
25913000 usd
CY2023Q4 us-gaap Inventory Gross
InventoryGross
25346000 usd
CY2024Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
7240000 usd
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
3808000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
18673000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
21538000 usd
us-gaap Inventory Write Down
InventoryWriteDown
3926000 usd
CY2024Q2 cweb Licensed Properties
LicensedProperties
13640000 usd
CY2023Q4 cweb Licensed Properties
LicensedProperties
14589000 usd
CY2024Q2 cweb Media Rights
MediaRights
3950000 usd
CY2023Q4 cweb Media Rights
MediaRights
4982000 usd
CY2024Q2 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1640000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2892000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2169000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1844000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1762000 usd
CY2024Q2 cweb Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
11884000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
22191000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
5359000 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
16832000 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2376000 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
14456000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-11057000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
2844000 usd
us-gaap Net Income Loss
NetIncomeLoss
-20691000 usd
us-gaap Net Income Loss
NetIncomeLoss
-67000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
157227855 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
152481470 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
156632263 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
152398273 shares
CY2024Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
278618 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
157227855 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
152760088 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
156632263 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
152398273 shares
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2024Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10106808 shares
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9411551 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10106808 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9690169 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.888
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.034
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q2 us-gaap Share Price
SharePrice
0.36
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5780134 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.75
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y6M21D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
1256648 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0.50
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4523486 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.83
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y11M8D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3442986 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.89
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y8M8D
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.38
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
946000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
872000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
7250766 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0.31
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
3021276 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.21
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
898685 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0.24
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
3162676 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
0.30
cweb Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Withheld In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWithheldInPeriod
627359 shares
cweb Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Withheld In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWithheldInPeriodWeightedAverageGrantDateFairValue
0.49
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
5583322 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0.26
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
237000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
624000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1079000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
999000 usd
CY2024Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
2776000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y2M1D
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
46000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
62000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.002
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.002
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2021Q1 cweb Payment For Business Combination Purchase Option
PaymentForBusinessCombinationPurchaseOption
8000000 usd
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
0001750155-24-000059-index-headers.html Edgar Link pending
0001750155-24-000059-index.html Edgar Link pending
0001750155-24-000059.txt Edgar Link pending
0001750155-24-000059-xbrl.zip Edgar Link pending
consultingagreementjaredst.htm Edgar Link pending
cweb-20240630.htm Edgar Link pending
cweb-20240630.xsd Edgar Link pending
ex311.htm Edgar Link pending
ex312.htm Edgar Link pending
ex321.htm Edgar Link pending
cweb-20240630_cal.xml Edgar Link unprocessable
cweb-20240630_def.xml Edgar Link unprocessable
cweb-20240630_lab.xml Edgar Link unprocessable
cweb-20240630_pre.xml Edgar Link unprocessable
cweb-20240630_htm.xml Edgar Link completed
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending